Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | UNK | UK199AA | IM / LL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | IM / LL |
Patient given Pentacel vaccine. Which consist of DTap, IPV & Hib. Patient did not receive Hib portion of vaccine. Manufacturer of vaccine Sanofi Paseur consulted. Writer instructed to give HIB portion of vaccine with 0.4% Chloride, no time frame recommended. Patient has no known signs, symptoms, or adverse reactions over the course of incident. Patients' legal guardian will be notified of diversion and instructed to bring patient into clinic to receive HIB portion of vaccine Staff retrained on how to properly administer vaccine to prevent future mistakes.
None known
None known
cetaminophen (TYLENOL) 160 mg/5 mL liquid Take 4.2 mL by mouth every 4 (four) hours as needed for fever cetirizine (ZYRTEC) 1 mg/mL syrup Take 2.5 mL by mouth once daily hydrocortisone 2.5 % ointment Apply topically 2 (two) times daily
No known allergies.
N/A